KCC4 Antibody

What is KCC4 and why are antibodies against it important in research?

KCC4 is encoded by the gene SLC12A7 (solute carrier family 12 member 7) in humans. It is a 1083-amino acid protein belonging to the SLC12A transporter family and functions primarily as a membrane-associated potassium-chloride cotransporter . KCC4 antibodies are crucial research tools for understanding the expression, localization, and functional regulation of this transporter in various experimental systems. These antibodies allow researchers to investigate KCC4's role in ion homeostasis, cell volume regulation, and transepithelial transport processes across different tissues and disease models. The protein contains glycosylation sites that can affect its function and cellular processing, making their detection through antibody-based methods particularly valuable for understanding post-translational regulation .

What applications are KCC4 antibodies validated for?

KCC4 antibodies are validated for multiple research applications, with varying degrees of optimization depending on the specific antibody. The primary applications include:

• Western Blot (WB): Most commonly validated application for detecting KCC4 protein expression levels

• Immunoprecipitation (IP): Used for isolating KCC4 protein complexes to study interaction partners

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of KCC4 levels

• Immunohistochemistry (IHC): For examining tissue localization of KCC4

When selecting a KCC4 antibody, it's important to verify that it has been validated for your specific application. For instance, while most commercial antibodies are validated for Western blot analysis, fewer have been rigorously tested for immunohistochemistry or immunoprecipitation applications .

How should I validate a new KCC4 antibody for my research?

Proper validation of a KCC4 antibody is essential for ensuring reliable and reproducible results:

• Positive and negative controls:

  • Use cells/tissues known to express KCC4 as positive controls

  • Include KCC4 knockout or knockdown samples as negative controls

• Multiple detection methods:

  • Compare results across different techniques (WB, IHC, IF)

  • Verify subcellular localization matches expected membrane pattern

• Specificity assessment:

  • Perform peptide competition assays

  • Test cross-reactivity with other KCC family members

  • Compare multiple antibodies targeting different KCC4 epitopes

• Functionality testing:

  • Verify that the antibody can detect changes in KCC4 expression or modification

  • Confirm detection of expected molecular weight species (considering glycosylation)

• Reproducibility assessment:

  • Test antibody across multiple experimental replicates

  • Evaluate batch-to-batch consistency

For heterologous expression systems, overexpression of tagged KCC4 (like FLAG-KCC4) can provide an additional validation method, as demonstrated in studies comparing antibody detection with tag-specific antibodies .

How does post-translational modification affect KCC4 detection by antibodies?

Post-translational modifications (PTMs) can significantly impact KCC4 antibody detection, potentially leading to experimental artifacts or misinterpretation:

• Acetylation effects:

  • KCC4 is acetylated at lysine 114 (K114), which affects protein stability and function

  • Antibodies may have differential reactivity with acetylated versus deacetylated forms

  • Treatment with deacetylase inhibitors like nicotinamide (NAM) decreases KCC4 protein levels by over 70% after 48 hours, potentially affecting detection thresholds

• Glycosylation considerations:

  • KCC4 contains glycosylation sites that modify its molecular weight

  • Antibodies targeting glycosylated epitopes may show variable binding depending on glycosylation status

  • Deglycosylation treatments before Western blotting may be necessary for consistent detection

• Experimental approach for studying PTM effects:

Understanding these modifications is critical for proper experimental design and interpretation when using KCC4 antibodies.

What experimental controls should I include when using KCC4 antibodies?

Robust experimental controls are essential for reliable KCC4 antibody-based research:

• Expression controls:

  • Positive control: Tissues/cells with known KCC4 expression (kidney cell lines)

  • Negative control: KCC4 knockout/knockdown samples

  • Overexpression control: Cells transfected with KCC4 expression constructs

• Specificity controls:

  • Peptide competition: Pre-incubation of antibody with immunizing peptide

  • Multiple antibodies: Use of different antibodies targeting distinct KCC4 epitopes

  • Related protein controls: Testing cross-reactivity with other KCC family members

• Technical controls:

  • Loading controls: Housekeeping proteins or membrane fraction markers

  • Transfer efficiency controls for Western blotting

  • Secondary antibody-only controls to assess background

• Treatment-specific controls:

  • When studying acetylation: Include NAM or NAD+ treatments as comparative controls

  • For protein stability studies: Include cycloheximide time course samples

• Mutant controls:

  • K114Q and K114R KCC4 mutants to control for acetylation state effects

  • Domain-specific mutants when studying regional epitopes

These comprehensive controls help ensure that observed signals are specific to KCC4 and accurately reflect its biological state.

How can I optimize Western blot protocols for KCC4 detection?

Optimizing Western blot protocols for KCC4 requires special considerations for this membrane-associated transporter:

• Sample preparation:

  • Use membrane protein extraction buffers containing 1-2% detergent

  • Include protease inhibitors to prevent degradation

  • Avoid excessive heating (keep ≤70°C) to prevent aggregation

  • Consider using 8M urea for challenging samples

• Gel electrophoresis:

  • Use 7-8% gels for better resolution of the 1083-amino acid KCC4 protein

  • Run gel at lower voltage (80-100V) for improved separation

  • Consider gradient gels for simultaneous detection of KCC4 and smaller proteins

• Transfer optimization:

  • Use wet transfer for more efficient transfer of large membrane proteins

  • Extended transfer times (overnight at low voltage) may improve results

  • Add 0.05-0.1% SDS to transfer buffer to aid large protein transfer

• Blocking and antibody incubation:

  • Test BSA vs. milk blocking (5% BSA often preferred for phospho-specific detection)

  • Optimize primary antibody dilution (typically 1:500-1:2000 for commercial antibodies)

  • Consider overnight primary antibody incubation at 4°C

• Detection considerations:

  • Use high-sensitivity ECL reagents for low abundance detection

  • Consider longer exposure times (KCC4 can have relatively low expression)

  • Quantify using linear range of detection

These optimizations can significantly improve detection sensitivity and specificity for KCC4 in Western blot applications.

What is the relationship between KCC4 and SIRT7, and how can antibodies help study it?

Research has revealed an important regulatory relationship between KCC4 and SIRT7 (a NAD+-dependent deacetylase) that can be studied using antibody-based approaches:

• Regulatory relationship:

  • SIRT7 deacetylates KCC4 at lysine 114 (K114)

  • This deacetylation increases KCC4 protein stability and functional activity

  • SIRT7 and KCC4 physically interact, with the interaction enhanced by NAD+ and reduced by NAM

• Experimental approaches using antibodies:

  • Co-immunoprecipitation: Using anti-FLAG antibodies to pull down FLAG-KCC4 and detect SIRT7 interaction

  • Acetylation detection: Using anti-acetyl-lysine antibodies to assess KCC4 acetylation status

  • Protein stability: Tracking KCC4 protein levels using anti-KCC4 antibodies following SIRT7 manipulation

• Key findings from antibody-based studies:

This regulatory mechanism suggests that SIRT7 activators might enhance KCC4 function, while deacetylase inhibitors could reduce KCC4 stability and activity - findings with potential therapeutic implications.

How can I design experiments to study KCC4 specificity in different tissues?

Designing tissue-specific KCC4 studies requires a multi-faceted approach:

• Expression profiling:

  • Use validated KCC4 antibodies for immunohistochemistry across tissue panels

  • Complement with qPCR for mRNA expression comparison

  • Consider single-cell approaches to identify cell-specific expression patterns

• Antibody validation for tissue specificity:

  • Test KCC4 antibodies on multiple tissue types with proper controls

  • Compare multiple antibodies targeting different KCC4 epitopes

  • Include tissue-specific knockout controls when available

• Functional analysis design:

  • Assess tissue-specific post-translational modifications like acetylation

  • Investigate tissue-dependent SIRT7-KCC4 interaction patterns

  • Design tissue-specific knockout or knockdown models

• Technical considerations:

  • Optimize tissue fixation and antigen retrieval for IHC applications

  • Consider tissue-specific extraction methods for consistent protein isolation

  • Use tissue-specific housekeeping genes/proteins as reference controls

• Comparative experimental approach:

This comprehensive approach enables more reliable comparison of KCC4 expression, localization, and regulation across different tissue contexts.

What challenges exist in detecting acetylated KCC4, and how can they be overcome?

Detecting acetylated KCC4 presents several technical challenges that require specialized approaches:

• Key challenges:

  • Low abundance of acetylated protein forms

  • Difficulty in generating acetylation site-specific antibodies

  • Limited mass spectrometry detection sensitivity for membrane proteins

  • Transient nature of acetylation modifications

• Experimental strategies:

  • Enrichment via immunoprecipitation before detection

  • Use of deacetylase inhibitors (NAM) to increase acetylated KCC4 pool

  • Application of acetylation-mimetic mutations (K114Q) for functional studies

  • Development of site-specific anti-acetyl-KCC4 antibodies

• Optimized detection protocol:

  • Immunoprecipitate KCC4 using validated antibodies

  • Perform Western blot with anti-acetyl-lysine antibodies

  • Compare acetylation levels with and without deacetylase inhibitors

  • Include total KCC4 detection as normalization control

• Alternative approaches when antibody-based detection is challenging:

  • Use indirect measurements such as comparing wild-type with K114R/Q mutants

  • Assess functional correlates of acetylation (KCC4 activity measurement)

  • Monitor protein stability as an indicator of acetylation status

This methodological framework addresses the specific difficulties in studying KCC4 acetylation, which is essential for understanding its regulation by deacetylases like SIRT7.

How can computational approaches enhance KCC4 antibody design and specificity?

Advanced computational methods offer powerful approaches to improve KCC4 antibody design:

• Biophysics-informed modeling applications:

  • Identification of distinct binding modes for different epitopes

  • Prediction of cross-reactivity with related KCC transporters

  • Design of antibodies with customized specificity profiles

  • Mitigation of experimental artifacts in antibody selection

• Implementation methodology:

  • Training models on high-throughput sequencing data from phage display experiments

  • Defining energy functions associated with each binding mode

  • Optimizing for specific high affinity for particular KCC4 epitopes

  • Designing for either high specificity or controlled cross-reactivity

• Advantages of computational approach:

  • Generation of antibody variants not present in initial libraries

  • Ability to discriminate between very similar epitopes

  • Customized specificity profiles for particular research applications

  • Prediction capabilities beyond experimentally tested antibodies

• Experimental validation workflow:

  • Generate computationally designed antibody sequences

  • Express and purify candidate antibodies

  • Test specificity against KCC4 and related proteins

  • Validate in multiple applications (WB, IP, IHC)

This computational framework, combined with experimental validation, offers significant advantages for developing next-generation KCC4 antibodies with enhanced specificity and application-specific optimization.

What methodologies are available for studying KCC4 in protein complexes?

Investigating KCC4 within protein complexes requires specialized approaches:

• Co-immunoprecipitation strategies:

  • Use KCC4 antibodies for pull-down followed by interaction partner identification

  • Perform reciprocal co-IP with antibodies against suspected interaction partners

  • Apply formaldehyde or DSS cross-linking to stabilize transient interactions

  • Include appropriate controls (IgG, knockout samples)

• Advanced protein complex isolation techniques:

  • Blue Native PAGE for membrane protein complexes

  • Size exclusion chromatography combined with Western blotting

  • Tandem affinity purification using tagged KCC4 constructs

  • Proximity labeling approaches (BioID, APEX)

• Mass spectrometry-based interactome analysis:

  • Sample preparation considerations for membrane proteins

  • Detergent selection critically affects complex stability

  • SILAC or TMT labeling for quantitative comparison

  • Bioinformatic filtering to identify high-confidence interactions

• Functional validation of interactions:

  • Mutagenesis of putative interaction domains

  • Cellular co-localization studies

  • Functional assays measuring KCC4 activity in presence/absence of partners

The SIRT7-KCC4 interaction study provides a methodological template, demonstrating how FLAG-tagged KCC4 immunoprecipitation can be used to confirm interaction with regulatory partners like SIRT7 .

How can KCC4 antibodies be used to investigate the relationship between protein stability and function?

KCC4 antibodies provide essential tools for exploring the connection between stability and function:

• Protein stability assessment techniques:

  • Cycloheximide chase assays with Western blot detection

  • Pulse-chase experiments with metabolic labeling

  • Monitoring KCC4 levels after treatment with stabilizing/destabilizing factors

  • Comparing wild-type KCC4 with stability-affecting mutants

• Correlation with functional measurements:

  • Research shows that deacetylation by SIRT7 increases both KCC4 stability and activity

  • NAM treatment decreases both KCC4 protein levels (by >70%) and activity (by 88%)

  • K114R mutation (mimicking deacetylation) exhibits higher expression and activity

• Experimental approach:

• Mechanistic investigation:

  • Ubiquitination assays to assess proteasomal degradation

  • Lysosomal inhibitor studies to evaluate alternative degradation pathways

  • Protein half-life calculations under various conditions

  • Structural studies to understand stability determinants

This research framework demonstrates how antibody-based detection can reveal fundamental relationships between post-translational modifications, protein stability, and transporter function.

What are the most effective approaches for using KCC4 antibodies in multiplexed detection systems?

Multiplexed detection of KCC4 alongside other proteins requires specialized methodologies:

• Multi-color immunofluorescence:

  • Careful selection of compatible fluorophores for KCC4 and other targets

  • Use of directly conjugated primary antibodies when available

  • Sequential staining protocols for technically challenging combinations

  • Spectral unmixing for separating overlapping signals

• Multiplex Western blotting strategies:

  • Sequential immunoblotting with stripping between detections

  • Simultaneous detection using antibodies from different species

  • Fluorescent Western blotting with spectrally distinct secondary antibodies

  • Size-based separation when detecting KCC4 interactors of different molecular weights

• Single-cell protein analysis:

  • Mass cytometry (CyTOF) for high-parameter protein detection

  • Imaging mass cytometry for tissue section analysis

  • Proximity ligation assay (PLA) for detecting KCC4-protein interactions

  • Microfluidic antibody capture for single-cell protein profiling

• Application example: Studying KCC4-SIRT7 interaction

  • Co-staining tissue sections for both KCC4 and SIRT7

  • PLA to visualize direct KCC4-SIRT7 interactions in situ

  • Mass cytometry to quantify KCC4, SIRT7, and acetylation markers simultaneously

  • Multiplex Western blotting to detect KCC4, SIRT7, and acetylated lysine

These multiplexed approaches allow researchers to study KCC4 in the context of its regulatory network, providing insights into complex cellular mechanisms that single-target detection cannot reveal.

How can I design experiments to evaluate antibody binding to different acetylation states of KCC4?

Designing experiments to evaluate antibody binding to different acetylation states requires sophisticated approaches:

• Antibody characterization strategy:

  • Test antibody recognition of wild-type KCC4 under different acetylation conditions

  • Compare detection of wild-type KCC4 with K114Q (acetylation mimic) and K114R (deacetylation mimic) mutants

  • Assess antibody binding after treatment with deacetylase inhibitors (NAM) or activators (NAD+)

  • Evaluate detection sensitivity across concentration ranges of differentially acetylated KCC4

• Experimental design for binding assessment:

• Advanced analytical approaches:

  • Surface plasmon resonance (SPR) to measure binding kinetics to different KCC4 forms

  • Isothermal titration calorimetry (ITC) for binding affinity determination

  • Hydrogen-deuterium exchange mass spectrometry to map epitope accessibility

  • Computational modeling of antibody-epitope interactions in different acetylation states

This comprehensive approach enables detailed characterization of antibody binding properties across different post-translational states of KCC4, critical for accurate experimental interpretation.

How can mathematical modeling enhance our understanding of KCC4 antibody kinetics?

Mathematical modeling offers powerful tools for analyzing KCC4 antibody behavior:

• Quantitative binding models:

  • Apply biophysics-informed modeling approaches similar to those used for antibody specificity

  • Incorporate multiple binding modes associated with different KCC4 epitopes

  • Model competition between antibodies for overlapping epitopes

  • Predict cross-reactivity with related transporter proteins

• Antibody neutralization kinetics:

  • Models similar to those developed for other targets can be adapted for KCC4

  • Joint kinetic analysis of antibody concentration and neutralization capacity

  • Prediction of long-term antibody activity profiles

  • Quantification of binding parameters across different experimental conditions

• Mathematical approach advantages:

  • Extraction of quantitative binding parameters from experimental data

  • Prediction of antibody behavior under conditions not tested experimentally

  • Optimization of experimental design for maximum information gain

  • Integration of data from multiple experimental approaches

• Implementation methodology:

  • Define appropriate differential equations describing antibody-antigen interactions

  • Fit models to experimental time-course data of antibody binding

  • Validate predictions with independent experiments

  • Use models to optimize antibody concentration and incubation conditions